Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Nash

Showing results (481-490 of 495) with videos related to

Pageof 50
Sort By:
Nucleic Acids Research|November 6, 2007
Gene Ontology annotations at SGD: new data sources and annotation methodsEurie L Hong, Rama Balakrishnan, Qing Dong, et al.
Neurology|November 26, 2008
Subcutaneous IGF-1 is not beneficial in 2-year ALS trialE J Sorenson, A J Windbank, J N Mandrekar, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|January 28, 2026
Rates and Risk Factors for Major Adverse Cardiovascular and Cerebrovascular Events after stroke due to intracerebral haemorrhage: systematic review and study-level meta-analysisVega Pratiwi Putri, Neshika Samarasekera, Tom James Moullaali, et al.
Lancet (London, England)|November 4, 2024
Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trialDavid J Werring, Hakim-Moulay Dehbi, Norin Ahmed, et al.
Lancet (London, England)|June 26, 2025
Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST)Hakim-Moulay Dehbi, Urs Fischer, Signild Åsberg, et al.
Stroke|May 22, 2025
Anticoagulation Timing in Acute Stroke With Atrial Fibrillation According to Chronic Kidney Disease: The OPTIMAS TrialPhilip S Nash, Hakim-Moulay Dehbi, Norin Ahmed, et al.
Stroke|April 1, 2026
Early Versus Delayed Anticoagulation in Acute Ischemic Stroke According to Atrial Fibrillation Subtype and Time of Diagnosis: Subgroup Analysis of the OPTIMAS Randomized Controlled TrialJames Lyon, Philip S Nash, Norin Ahmed, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 30, 2026
Early Versus Delayed Anticoagulation in Acute Ischaemic Stroke with Atrial Fibrillation According to Infarct Volume and Location: a Prespecified Subgroup Analysis of the OPTIMAS Randomised Controlled TrialPhilip S Nash, Jonathan Best, James Lyon, et al.
Physical Review Letters|December 5, 2025
Constraining the Synthesis of the Lightest p Nucleus ^{74}SeA Tsantiri, A Spyrou, E C Good, et al.
Nucleic Acids Research|December 19, 2003
The Gene Ontology (GO) database and informatics resourceM A Harris, J Clark, A Ireland, et al.
Pageof 50

Showing results (481-490 of 495) with videos related to

Sort By:
Pageof 50
Nucleic Acids Research|November 6, 2007
Gene Ontology annotations at SGD: new data sources and annotation methodsEurie L Hong, Rama Balakrishnan, Qing Dong, et al.
Neurology|November 26, 2008
Subcutaneous IGF-1 is not beneficial in 2-year ALS trialE J Sorenson, A J Windbank, J N Mandrekar, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|January 28, 2026
Rates and Risk Factors for Major Adverse Cardiovascular and Cerebrovascular Events after stroke due to intracerebral haemorrhage: systematic review and study-level meta-analysisVega Pratiwi Putri, Neshika Samarasekera, Tom James Moullaali, et al.
Lancet (London, England)|November 4, 2024
Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trialDavid J Werring, Hakim-Moulay Dehbi, Norin Ahmed, et al.
Lancet (London, England)|June 26, 2025
Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST)Hakim-Moulay Dehbi, Urs Fischer, Signild Åsberg, et al.
Stroke|May 22, 2025
Anticoagulation Timing in Acute Stroke With Atrial Fibrillation According to Chronic Kidney Disease: The OPTIMAS TrialPhilip S Nash, Hakim-Moulay Dehbi, Norin Ahmed, et al.
Stroke|April 1, 2026
Early Versus Delayed Anticoagulation in Acute Ischemic Stroke According to Atrial Fibrillation Subtype and Time of Diagnosis: Subgroup Analysis of the OPTIMAS Randomized Controlled TrialJames Lyon, Philip S Nash, Norin Ahmed, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 30, 2026
Early Versus Delayed Anticoagulation in Acute Ischaemic Stroke with Atrial Fibrillation According to Infarct Volume and Location: a Prespecified Subgroup Analysis of the OPTIMAS Randomised Controlled TrialPhilip S Nash, Jonathan Best, James Lyon, et al.
Physical Review Letters|December 5, 2025
Constraining the Synthesis of the Lightest p Nucleus ^{74}SeA Tsantiri, A Spyrou, E C Good, et al.
Nucleic Acids Research|December 19, 2003
The Gene Ontology (GO) database and informatics resourceM A Harris, J Clark, A Ireland, et al.
Pageof 50